CRL-1072

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCRL-1072
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsHerpes SimplexHepatitis BBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCytrx Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytrx Corp
Active IndicationsN/A
Inactive IndicationsHerpes SimplexHepatitis BBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A